Skip to main content
Professional Technical IVT

immunosuppressive protocol

Standardized medication regimen used to prevent organ rejection in pediatric kidney transplant recipients.

Full Definition

An immunosuppressive protocol is a carefully designed combination of medications used to suppress the immune system and prevent rejection of transplanted kidneys in children. Typical protocols include induction therapy (often with antibodies like basiliximab or thymoglobulin) followed by maintenance therapy with multiple agents such as tacrolimus or cyclosporine, mycophenolate, and prednisone. Pediatric protocols require special consideration for growth, development, and age-specific dosing. The goal is to achieve adequate immunosuppression while minimizing side effects such as infection, malignancy, nephrotoxicity, and growth impairment. Protocols are individualized based on patient risk factors and regularly monitored through drug levels and biopsy results.

Usage

Usage note: Often shortened to 'immunosuppression' in clinical notes; distinguish from general immunotherapy.

In Context

  • "The patient was started on a standard pediatric immunosuppressive protocol following kidney transplantation." — Post-transplant care plan
  • "Modification of the immunosuppressive protocol was required due to evidence of acute rejection on biopsy." — Transplant nephrology progress note

Also known as

antirejection regimen transplant immunosuppression

Don't confuse with

immunotherapy protocol chemotherapy protocol

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON